Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Hurle

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Pharmacology and Therapeutics|February 28, 2013
Computational drug repositioning: from data to therapeuticsM R Hurle, L Yang, Q Xie, et al.
Biochemistry|May 8, 1990
Denaturant-dependent folding of bovine pancreatic trypsin inhibitor mutants with two intact disulfide bondsM R Hurle, C B Marks, P A Kosen, et al.
Protein Engineering|September 1, 1993
Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffoldG Lee, W Chan, M R Hurle, et al.
Proteins|January 1, 1987
Prediction of the tertiary structure of the alpha-subunit of tryptophan synthaseM R Hurle, C R Matthews, F E Cohen, et al.
Biochemistry|May 20, 1986
Effects of the phenylalanine-22----leucine, glutamic acid-49----methionine, glycine-234----aspartic acid, and glycine-234----lysine mutations on the folding and stability of the alpha subunit of tryptophan synthase from Escherichia coliA M Beasty, M R Hurle, J T Manz, et al.
Molecular Immunology|February 1, 1996
Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesisA Truneh, M Reddy, P Ryan, et al.
Protein Science : a Publication of the Protein Society|January 1, 1992
Comparison of solution structures of mutant bovine pancreatic trypsin inhibitor proteins using two-dimensional nuclear magnetic resonanceM R Hurle, C D Eads, D A Pearlman, et al.
Oncogene|August 6, 1999
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathwayP Chaturvedi, W K Eng, Y Zhu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Pharmacology and Therapeutics|February 28, 2013
Computational drug repositioning: from data to therapeuticsM R Hurle, L Yang, Q Xie, et al.
Biochemistry|May 8, 1990
Denaturant-dependent folding of bovine pancreatic trypsin inhibitor mutants with two intact disulfide bondsM R Hurle, C B Marks, P A Kosen, et al.
Protein Engineering|September 1, 1993
Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffoldG Lee, W Chan, M R Hurle, et al.
Proteins|January 1, 1987
Prediction of the tertiary structure of the alpha-subunit of tryptophan synthaseM R Hurle, C R Matthews, F E Cohen, et al.
Biochemistry|May 20, 1986
Effects of the phenylalanine-22----leucine, glutamic acid-49----methionine, glycine-234----aspartic acid, and glycine-234----lysine mutations on the folding and stability of the alpha subunit of tryptophan synthase from Escherichia coliA M Beasty, M R Hurle, J T Manz, et al.
Molecular Immunology|February 1, 1996
Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesisA Truneh, M Reddy, P Ryan, et al.
Protein Science : a Publication of the Protein Society|January 1, 1992
Comparison of solution structures of mutant bovine pancreatic trypsin inhibitor proteins using two-dimensional nuclear magnetic resonanceM R Hurle, C D Eads, D A Pearlman, et al.
Oncogene|August 6, 1999
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathwayP Chaturvedi, W K Eng, Y Zhu, et al.
Pageof 2